Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

IFIT1 polymorphisms predict interferon-α treatment efficiency for hepatitis B virus infection.

Xie DY, Wang SM, Yang JM, Wang LH, Chen HY, Huai C, Shang J, Mao Q, Lei CL, Luo GH, Qian J, Lu DR.

World J Gastroenterol. 2016 Nov 28;22(44):9813-9821.

2.

Sex Differences in Plasmacytoid Dendritic Cell Levels of IRF5 Drive Higher IFN-α Production in Women.

Griesbeck M, Ziegler S, Laffont S, Smith N, Chauveau L, Tomezsko P, Sharei A, Kourjian G, Porichis F, Hart M, Palmer CD, Sirignano M, Beisel C, Hildebrandt H, Cénac C, Villani AC, Diefenbach TJ, Le Gall S, Schwartz O, Herbeuval JP, Autran B, Guéry JC, Chang JJ, Altfeld M.

J Immunol. 2015 Dec 1;195(11):5327-36. doi: 10.4049/jimmunol.1501684. Epub 2015 Oct 30.

3.

Genetic analysis of the pathogenic molecular sub-phenotype interferon-alpha identifies multiple novel loci involved in systemic lupus erythematosus.

Kariuki SN, Ghodke-Puranik Y, Dorschner JM, Chrabot BS, Kelly JA, Tsao BP, Kimberly RP, Alarcón-Riquelme ME, Jacob CO, Criswell LA, Sivils KL, Langefeld CD, Harley JB, Skol AD, Niewold TB.

Genes Immun. 2015 Jan-Feb;16(1):15-23. doi: 10.1038/gene.2014.57. Epub 2014 Oct 23.

4.

The IRF5-TNPO3 association with systemic lupus erythematosus has two components that other autoimmune disorders variably share.

Kottyan LC, Zoller EE, Bene J, Lu X, Kelly JA, Rupert AM, Lessard CJ, Vaughn SE, Marion M, Weirauch MT, Namjou B, Adler A, Rasmussen A, Glenn S, Montgomery CG, Hirschfield GM, Xie G, Coltescu C, Amos C, Li H, Ice JA, Nath SK, Mariette X, Bowman S; UK Primary Sjögren's Syndrome Registry, Rischmueller M, Lester S, Brun JG, Gøransson LG, Harboe E, Omdal R, Cunninghame-Graham DS, Vyse T, Miceli-Richard C, Brennan MT, Lessard JA, Wahren-Herlenius M, Kvarnström M, Illei GG, Witte T, Jonsson R, Eriksson P, Nordmark G, Ng WF; UK Primary Sjögren's Syndrome Registry, Anaya JM, Rhodus NL, Segal BM, Merrill JT, James JA, Guthridge JM, Scofield RH, Alarcon-Riquelme M, Bae SC, Boackle SA, Criswell LA, Gilkeson G, Kamen DL, Jacob CO, Kimberly R, Brown E, Edberg J, Alarcón GS, Reveille JD, Vilá LM, Petri M, Ramsey-Goldman R, Freedman BI, Niewold T, Stevens AM, Tsao BP, Ying J, Mayes MD, Gorlova OY, Wakeland W, Radstake T, Martin E, Martin J, Siminovitch K, Moser Sivils KL, Gaffney PM, Langefeld CD, Harley JB, Kaufman KM.

Hum Mol Genet. 2015 Jan 15;24(2):582-96. doi: 10.1093/hmg/ddu455. Epub 2014 Sep 8.

5.

Interferon regulatory factor 3 as key element of the interferon signature in plasmacytoid dendritic cells from systemic lupus erythematosus patients: novel genetic associations in the Mexican mestizo population.

Santana-de Anda K, Gómez-Martín D, Monsivais-Urenda AE, Salgado-Bustamante M, González-Amaro R, Alcocer-Varela J.

Clin Exp Immunol. 2014 Dec;178(3):428-37. doi: 10.1111/cei.12429.

6.

Identification of three new cis-regulatory IRF5 polymorphisms: in vitro studies.

Alonso-Perez E, Fernandez-Poceiro R, Lalonde E, Kwan T, Calaza M, Gomez-Reino JJ, Majewski J, Gonzalez A.

Arthritis Res Ther. 2013 Aug 13;15(4):R82. doi: 10.1186/ar4262.

7.

RNA-Seq for enrichment and analysis of IRF5 transcript expression in SLE.

Stone RC, Du P, Feng D, Dhawan K, Rönnblom L, Eloranta ML, Donnelly R, Barnes BJ.

PLoS One. 2013;8(1):e54487. doi: 10.1371/journal.pone.0054487. Epub 2013 Jan 18.

8.

Recent insights into the genetic basis of systemic lupus erythematosus.

Rullo OJ, Tsao BP.

Ann Rheum Dis. 2013 Apr;72 Suppl 2:ii56-61. doi: 10.1136/annrheumdis-2012-202351. Epub 2012 Dec 19. Review.

9.

Interferon regulatory factor 5 in the pathogenesis of systemic lupus erythematosus.

Cham CM, Ko K, Niewold TB.

Clin Dev Immunol. 2012;2012:780436. doi: 10.1155/2012/780436. Epub 2012 Nov 1. Review.

10.

Pleiotropic IFN-dependent and -independent effects of IRF5 on the pathogenesis of experimental lupus.

Xu Y, Lee PY, Li Y, Liu C, Zhuang H, Han S, Nacionales DC, Weinstein J, Mathews CE, Moldawer LL, Li SW, Satoh M, Yang LJ, Reeves WH.

J Immunol. 2012 Apr 15;188(8):4113-21. doi: 10.4049/jimmunol.1103113. Epub 2012 Mar 14.

11.

Clinical and serological manifestations associated with interferon-α levels in childhood-onset systemic lupus erythematosus.

Postal M, Sinicato NA, Peliçari KO, Marini R, Lavras Costallat LT, Appenzeller S.

Clinics (Sao Paulo). 2012;67(2):157-62.

12.

Type I interferon and systemic lupus erythematosus.

Elkon KB, Stone VV.

J Interferon Cytokine Res. 2011 Nov;31(11):803-12. doi: 10.1089/jir.2011.0045. Epub 2011 Aug 22. Review.

13.

A functional variant in microRNA-146a promoter modulates its expression and confers disease risk for systemic lupus erythematosus.

Luo X, Yang W, Ye DQ, Cui H, Zhang Y, Hirankarn N, Qian X, Tang Y, Lau YL, de Vries N, Tak PP, Tsao BP, Shen N.

PLoS Genet. 2011 Jun;7(6):e1002128. doi: 10.1371/journal.pgen.1002128. Epub 2011 Jun 30.

14.

Cis-regulation of IRF5 expression is unable to fully account for systemic lupus erythematosus association: analysis of multiple experiments with lymphoblastoid cell lines.

Alonso-Perez E, Suarez-Gestal M, Calaza M, Kwan T, Majewski J, Gomez-Reino JJ, Gonzalez A.

Arthritis Res Ther. 2011 May 31;13(3):R80. doi: 10.1186/ar3343.

15.

Interferon regulatory factors in human lupus pathogenesis.

Salloum R, Niewold TB.

Transl Res. 2011 Jun;157(6):326-31. doi: 10.1016/j.trsl.2011.01.006. Epub 2011 Feb 8. Review.

16.

Genetic susceptibility to systemic lupus erythematosus in the genomic era.

Deng Y, Tsao BP.

Nat Rev Rheumatol. 2010 Dec;6(12):683-92. doi: 10.1038/nrrheum.2010.176. Epub 2010 Nov 9. Review.

Supplemental Content

Support Center